PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -69.39% | -73.35% | -240.83% | -232.41% | 7.89% |
| Total Depreciation and Amortization | -12.32% | -10.26% | 70.08% | 65.86% | -27.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.31% | 6.75% | -78.77% | -74.35% | 101.11% |
| Change in Net Operating Assets | -- | -- | 10.69% | 12.90% | -- |
| Cash from Operations | -148.78% | -154.60% | -149.71% | -143.55% | 42.95% |
| Capital Expenditure | -169.15% | -175.52% | 92.17% | 92.34% | -93.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -169.15% | -175.52% | 92.17% | 92.34% | -114.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -27.81% | -27.81% | -22.84% | -22.84% | -31.01% |
| Issuance of Common Stock | -- | -- | 490.18% | 490.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -60.70% | -60.70% | -- |
| Cash from Financing | -101.00% | -101.02% | 523.22% | 507.83% | 16,695.28% |
| Foreign Exchange rate Adjustments | 205.15% | 207.63% | 288.68% | 283.88% | -472.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.02% | -283.20% | 2,812.13% | 2,745.13% | 181.07% |